oglufanide disodium

DRUG3 trials

Sponsors

University of Southern California, Cytran

Conditions

Colorectal CancerOvarian CancerPrimary Peritoneal Cavity Cancer

Phase 1

IM-862 in Treating Patients With Recurrent Ovarian Cancer

CompletedNCT00003773

University of Southern CaliforniaOvarian Cancer

Start: 1999-02-28End: 2001-08-31Updated: 2014-05-22

Phase 2

Chemotherapy Plus IM-862 in Treating Patients With Metastatic Colorectal Cancer

TerminatedNCT00006037

University of Southern CaliforniaColorectal Cancer

Start: 1999-11-30End: 2001-11-30Updated: 2014-05-22

Combination Chemotherapy Plus IM-862 in Treating Patients With Resected Stage III Ovarian Cancer or Primary Peritoneal Cancer

CytranOvarian Cancer, Primary Peritoneal Cavity Cancer

Start: 2001-01-31Updated: 2013-11-06